About Reducose

Reducose is a plant-based, proprietary dietary supplement for healthy blood sugar balance. It is a water extract of mulberry (Morus alba) leaves, a plant that has been used for centuries around the world as a food and medicinal plant due to its nutrient profile and health benefits. Reducose has undergone rigorous safety and efficacy testing and it has been shown to help modulate blood sugar spikes after eating by up to 40%*.

Reducose is the result of a decade of R&D and is backed by 6 human clinical studies with additional studies underway.

About Phynova

Phynova is a British life science company based outside Oxford that develops and commercializes proprietary dietary supplements and functional food ingredients. Phynova has almost 20 years of experience creating plant-based products that support optimum metabolic health.

Phynova’s innovative products have been recognised by national and international awards committees. Reducose was runner-up in NutraIngredients Ingredient of the Year award for 2016. The UK’s funding body for innovative corporate R&D recognised the development of Reducose in the 2016 edion of the Innovate UK SME Innovation Awards, where it was runner up in the category ‘Innovation leading to new markets’. Global Health and Pharma named Phynova ‘Global leader in plant based compounds and pharmaceuticals’ and also recognised Phynova Joint and Muscle Relief Tablets as ‘Best natural pain reliever’ in their 2016 awards.

Focus On The Science

Andrew Gallagher

Global Head of Science

For the past 14 years, Andrew has been developing healthcare products derived from plants for the pharmaceutical and consumer healthcare markets. His experience covers the full value chain, from early discovery to clinical development and commercialisation. Andrew’s focus over the past few years has been in metabolic health, where he helped develop Reducose and oversaw the clinical trial program.

Andrew holds several academic degrees including an MBA in Finance, MSc in Biology, BSc Honours in Biological Science, and a BSc in Chemistry and Cell Biology. Andrew is currently working part-time on a PhD in Health Economics where is researching the cost effectiveness of lifestyle interventions for treating chronic diseases.

Contact Us


Phynova USA
11225 SE 6th Street
Ste. 230
WA 98004




Call : 509-761-9261